Biologic enhancement of spinal fusion with bone morphogenetic proteins: current position based on clinical evidence and future perspective.
作者信息
Kaito Takashi
机构信息
Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
出版信息
J Spine Surg. 2016 Dec;2(4):357-358. doi: 10.21037/jss.2016.12.11.
Abstract
摘要
相似文献
1
Biologic enhancement of spinal fusion with bone morphogenetic proteins: current position based on clinical evidence and future perspective.骨形态发生蛋白对脊柱融合的生物学增强作用：基于临床证据的现状与未来展望
J Spine Surg. 2016 Dec;2(4):357-358. doi: 10.21037/jss.2016.12.11.
2
How does recombinant human bone morphogenetic protein-4 enhance posterior spinal fusion?重组人骨形态发生蛋白-4如何增强后路脊柱融合？
Spine (Phila Pa 1976). 2002 Mar 1;27(5):467-74. doi: 10.1097/00007632-200203010-00006.
3
Biologic enhancement of spinal fusion.脊柱融合的生物增强
Orthop Clin North Am. 1998 Oct;29(4):621-31. doi: 10.1016/s0030-5898(05)70035-3.
4
Bone morphogenetic proteins and spinal surgery.骨形态发生蛋白与脊柱外科手术
Spine (Phila Pa 1976). 2003 Aug 1;28(15 Suppl):S64-73. doi: 10.1097/01.BRS.0000076901.49567.25.
5
The Biological Enhancement of Spinal Fusion for Spinal Degenerative Disease.脊柱退行性疾病的脊柱融合的生物学增强。
Int J Mol Sci. 2018 Aug 17;19(8):2430. doi: 10.3390/ijms19082430.
6
Current use of biologic graft extenders for spinal fusion.生物移植物增强剂在脊柱融合术中的当前应用。
J Neurosurg Sci. 2012 Sep;56(3):203-7.
7
Application of Cytokines of the Bone Morphogenetic Protein (BMP) Family in Spinal Fusion - Effects on the Bone, Intervertebral Disc and Mesenchymal Stromal Cells.骨形态发生蛋白（BMP）家族细胞因子在脊柱融合中的应用——对骨、椎间盘和间充质基质细胞的影响
Curr Stem Cell Res Ther. 2019;14(8):618-643. doi: 10.2174/1574888X14666190628103528.
8
Bone morphogenetic protein-associated complications in pediatric spinal fusion in the early postoperative period: an analysis of 4658 patients and review of the literature.儿童脊柱融合术后早期与骨形态发生蛋白相关的并发症：4658例患者分析及文献综述
J Neurosurg Pediatr. 2014 Dec;14(6):635-43. doi: 10.3171/2014.8.PEDS13665. Epub 2014 Oct 10.
9
Experimental spinal fusion with recombinant human bone morphogenetic protein-2.重组人骨形态发生蛋白-2的实验性脊柱融合术
Spine (Phila Pa 1976). 1995 Jun 15;20(12):1326-37.
10
Biologic enhancement of spinal fusion.脊柱融合的生物增强作用。
Spine (Phila Pa 1976). 1995 Dec 15;20(24 Suppl):113S-123S.
引用本文的文献
1
Collagen-hydroxyapatite based scaffolds for bone trauma and regeneration: recent trends and future perspectives.基于胶原-羟基磷灰石的骨创伤和再生支架：最新趋势和未来展望。
Nanomedicine (Lond). 2024;19(18-20):1689-1709. doi: 10.1080/17435889.2024.2375958. Epub 2024 Aug 20.
2
BMP and TGFβ use and release in bone regeneration.骨再生中 BMP 和 TGFβ 的应用和释放。
Turk J Med Sci. 2020 Nov 3;50(SI-2):1707-1722. doi: 10.3906/sag-2003-127.
3
Dual pitch titanium-coated pedicle screws improve initial and early fixation in a polyetheretherketone rod semi-rigid fixation system in sheep.双螺距钛涂层椎弓根螺钉在羊的聚醚醚酮棒半刚性固定系统中提高初始和早期固定效果。
Chin Med J (Engl). 2019 Nov 5;132(21):2594-2600. doi: 10.1097/CM9.0000000000000335.
4
[Sustained release of recombinant human bone morphogenetic protein-2 combined with stromal vascular fraction cells in promoting posterolateral spinal fusion in rat model].重组人骨形态发生蛋白-2与基质血管成分细胞的持续释放联合促进大鼠模型后外侧脊柱融合
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2017 Jul 15;31(7):862-869. doi: 10.7507/1002-1892.201703043.
5
Bone grafts and biomaterials substitutes for bone defect repair: A review.用于骨缺损修复的骨移植材料和生物材料替代品：综述
Bioact Mater. 2017 Jun 7;2(4):224-247. doi: 10.1016/j.bioactmat.2017.05.007. eCollection 2017 Dec.
本文引用的文献
1
Use of Recombinant Bone Morphogenetic Protein Is Associated With Reduced Risk of Reoperation After Spine Fusion for Adult Spinal Deformity.重组骨形态发生蛋白的使用与成人脊柱畸形脊柱融合术后再次手术风险降低相关。
Spine (Phila Pa 1976). 2016 Jan;41(1):E15-21. doi: 10.1097/BRS.0000000000001173.
2
Use of bone morphogenetic protein among patients undergoing fusion for degenerative diagnoses in the United States, 2002 to 2012.2002年至2012年美国退行性疾病诊断患者融合手术中骨形态发生蛋白的使用情况。
Spine J. 2015 Apr 1;15(4):692-9. doi: 10.1016/j.spinee.2014.12.010. Epub 2014 Dec 15.
3
Effect of Intermittent Administration of Teriparatide (Parathyroid Hormone 1-34) on Bone Morphogenetic Protein-Induced Bone Formation in a Rat Model of Spinal Fusion.间歇性给予特立帕肽（甲状旁腺激素1-34）对脊柱融合大鼠模型中骨形态发生蛋白诱导的骨形成的影响
J Bone Joint Surg Am. 2014 Jul 2;96(13):e107. doi: 10.2106/JBJS.M.01097.
4
Effectiveness and harms of recombinant human bone morphogenetic protein-2 in spine fusion: a systematic review and meta-analysis.重组人骨形态发生蛋白-2 在脊柱融合中的有效性和危害：系统评价和荟萃分析。
Ann Intern Med. 2013 Jun 18;158(12):890-902. doi: 10.7326/0003-4819-158-12-201306180-00006.
5
Safety and effectiveness of recombinant human bone morphogenetic protein-2 for spinal fusion: a meta-analysis of individual-participant data.重组人骨形态发生蛋白-2 用于脊柱融合的安全性和有效性：一项个体参与者数据的荟萃分析。
Ann Intern Med. 2013 Jun 18;158(12):877-89. doi: 10.7326/0003-4819-158-12-201306180-00005.
6
The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis: a long-term (>4 years) pivotal study.OP-1（重组人骨形态发生蛋白-7）替代自体髂骨植骨用于腰椎后外侧融合术的安全性和有效性：一项长期（>4年）关键研究。
Spine (Phila Pa 1976). 2008 Dec 15;33(26):2850-62. doi: 10.1097/BRS.0b013e31818a314d.
7
Bone morphogenetic proteins.骨形态发生蛋白
Growth Factors. 2004 Dec;22(4):233-41. doi: 10.1080/08977190412331279890.
Zotero 插件